TGFBR2 and colonic neoplasm: In contrast, neither ligand was growth suppressive in the absence of SMAD4 in ACVR2/TGFBR2 wild type/SMAD4-null SW480 colon cancer cells or following SMAD4 knockdown in SMAD4 wild type FET cells (Figure 1A).